NewGenIvf Group Limited (NASDAQ:NIVF – Get Free Report) saw a significant drop in short interest during the month of March. As of March 31st, there was short interest totalling 142,100 shares, a drop of 25.0% from the March 15th total of 189,400 shares. Based on an average daily volume of 2,960,000 shares, the days-to-cover ratio is presently 0.0 days. Currently, 20.4% of the shares of the company are short sold.
Institutional Investors Weigh In On NewGenIvf Group
A hedge fund recently raised its stake in NewGenIvf Group stock. XTX Topco Ltd increased its holdings in NewGenIvf Group Limited (NASDAQ:NIVF – Free Report) by 400.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 73,801 shares of the company’s stock after acquiring an additional 59,059 shares during the quarter. XTX Topco Ltd owned approximately 0.73% of NewGenIvf Group worth $30,000 at the end of the most recent quarter. 66.24% of the stock is owned by institutional investors.
NewGenIvf Group Price Performance
NewGenIvf Group stock opened at $0.28 on Monday. NewGenIvf Group has a fifty-two week low of $0.26 and a fifty-two week high of $65.60. The stock has a 50-day simple moving average of $1.18 and a 200-day simple moving average of $7.09.
NewGenIvf Group Company Profile
NewGenIVF Group Ltd. operates as an assisted reproductive services provider. It focuses on providing fertility treatments to fulfil the dreams of building families. The firm offers in-vitro fertilization treatment service, comprising traditional IVF and egg donation, and surrogacy and ancillary caring services.
Further Reading
- Five stocks we like better than NewGenIvf Group
- How to Use High Beta Stocks to Maximize Your Investing Profits
- With a 60%+ Upside, There’s Plenty to Love About Lovesac
- Growth Stocks: What They Are, Examples and How to Invest
- J.B. Hunt Transport Overcorrects Into a Buying Opportunity
- How to Short Nasdaq: An Easy-to-Follow Guide
- AppLovin: Can Record Profits Overcome Market Skepticism?
Receive News & Ratings for NewGenIvf Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NewGenIvf Group and related companies with MarketBeat.com's FREE daily email newsletter.